ExeVir Bio BV (“ExeVir”), announces its participation in the Bio-Partnering at JPM taking place in San Francisco on 9-12 January 2023.

Our CEO and COO are attending this partnering event in person to meet interesting biotech companies and investors, exploring opportunities to collaborate in delivering new medicines to prevent and treat infectious diseases in patients.